表紙
市場調查報告書

藥物研發資訊學市場 - 成長,趨勢,及預測(2019-2024)

Drug Discovery Informatics Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 871391
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
Back to Top
藥物研發資訊學市場 - 成長,趨勢,及預測(2019-2024) Drug Discovery Informatics Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年05月01日內容資訊: 英文 114 Pages
簡介

本報告提供全球藥物研發資訊學市場的相關調查,市場概況和成長要素、阻礙因素,各功能、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊彙整。

目錄

第1章 簡介

  • 研究成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 資料探勘與分析的技術進步
    • 藥物研發相關研究開發的增加
  • 市場阻礙因素
    • 資訊學軟體的高價格與安裝成本
  • 波特五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各功能
    • 序列測定及標的資料分析
    • 對接
    • 分子模擬
    • 程序庫和資料庫的準備
    • 其他
  • 各終端用戶
    • 製藥及生物科技企業
    • 受託研究機構(CROS)
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東及非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Collaborative Drug Discovery
    • Dassault Systmes
    • GVK Biosciences
    • IBM
    • Infosys
    • IO Informatics
    • Jubilant Life Sciences
    • Novo Informatics
    • Perkinelmer
    • Thermo Fisher Scientific

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 57046

Market Overview

The cost of research and development in drug discovery is rising significantly. Most clinical trials for drugs are sponsored by pharmaceutical companies, who spend millions of money for drug development which in turn is the primary reason why their products are so expensive. Drug discovery is the area of research and development that accounts for the most amount of time and money. The time frame can range from 4-25 years and costs can be thousands of millions of dollars. The healthcare industry was facing major challenges such as increasing costs, unacceptable error rates, and dissatisfied patients and providers. Drug Discovery Informatics uses sophisticated bioinformatics algorithms to process data related to drug, disease, protein, pathway, gene expression, sequence data and extend the flexible architecture to build new customized approaches and algorithms for diverse aspects of drug discovery which would help to minimize the cost for drug development. The other factor such as pharmaceutical companies gaining more interest in drug discovery and urgent need to limit the drug discovery and development cost are driving the Drug Discovery Informatics Market to grow.

Scope of the Report

The information technology supporting the drug discovery process is known as drug discovery bioinformatics. With the vast amount of biochemical data generated from experiments conducted by research laboratories around the globe, there is a strong demand for software to analyze and manage the data effectively which will drive the market studied.

Key Market Trends

Pharmaceutical and Biotechnology Companies is Expected to Grow with High CAGR in the Forecasted Period

Informatics analysis in drug discovery not only accelerate drug target identification and drug candidate screening and refinement but also facilitate characterization of side effects and predict drug resistance. High-throughput data such as genomic, epigenetic, genome architecture, cistromic, transcriptomic, proteomic, and ribosome profiling data have all made a significant contribution to mechanism-based drug discovery. Informaticians in drug discovery use high-throughput molecular data in comparisons between symptom-carriers (patients, animal disease models, cancer cell lines, etc.) and normal controls. Also, only 10 percent of drug molecules which are identified in research make it through development which means that many potential drugs do not make it to market, and expensive time and resources are invested m molecules that will generate no revenue. So, simulation and informatics can significantly increase the odds by improving the efficiency of drug development, cutting costs, and improving margins for pharmaceutical and biotechnology companies. Thus increasing the application of Informatics in drug discovery is augmenting the growth of the market. Also, major pharmaceutical companies have established high throughput screening facilities and have invested in automation to screen large compound libraries. There is pharmaceutical bioinformatics which is a new discipline in the area of the genomics revolution. It is central to biomedicine with application in areas like pharmacy, medicine, biology, and medicinal chemistry which will help in the growth of the market in future forecast.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. In North America region, the United States holds the largest market share and this is due to the increasing R&D on drug discovery and technological advancements in data mining and analytic which has helped the growth of the Drug Discovery Informatics market in the country. The advancement terms of informatics research are well supported by the healthcare IT sectors and demand for new drugs in lesser timeline and cost for infrastructure. These factors drive the importance and market growth in the North America region better than other parts of the world.

Competitive Landscape

The Drug Discovery Informatics market is competitive and consists of a few major players. In terms of market share, these major players currently dominate the market. Some of the major players of the market are GVK Biosciences, Infosys, IBM, and PerkinElmer among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancements in Data Mining and Analytics
    • 4.2.2 Increasing R&D on Drug Discovery
  • 4.3 Market Restraints
    • 4.3.1 High Pricing and Setup Cost of Informatics Software
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Function
    • 5.1.1 Sequencing & Target Data Analysis
    • 5.1.2 Docking
    • 5.1.3 Molecular Modelling
    • 5.1.4 Libraries & Database Preparation
    • 5.1.5 Others
  • 5.2 End User
    • 5.2.1 Pharmaceutical and Biotechnology Companies
    • 5.2.2 Contract Research Organizations (CROS)
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Collaborative Drug Discovery
    • 6.1.2 Dassault Systmes
    • 6.1.3 GVK Biosciences
    • 6.1.4 IBM
    • 6.1.5 Infosys
    • 6.1.6 IO Informatics
    • 6.1.7 Jubilant Life Sciences
    • 6.1.8 Novo Informatics
    • 6.1.9 Perkinelmer
    • 6.1.10 Thermo Fisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top